Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1994 1
1995 1
1996 2
2000 1
2001 1
2003 2
2004 2
2005 3
2007 1
2008 1
2009 1
2010 1
2011 1
2012 2
2014 1
2015 2
2016 6
2017 2
2018 2
2019 2
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Transmyocardial laser revascularization versus medical therapy for refractory angina.
Briones E, Lacalle JR, Marin-Leon I, Rueda JR. Briones E, et al. Cochrane Database Syst Rev. 2015 Feb 27;2015(2):CD003712. doi: 10.1002/14651858.CD003712.pub3. Cochrane Database Syst Rev. 2015. PMID: 25721946 Free PMC article. Review.
In spite of the improvement in the efficacy of available revascularization treatments, a subgroup of patients continue suffering from refractory angina. Transmyocardial laser revascularization (TMLR) has been proposed to improve the clinical situation of these patie …
In spite of the improvement in the efficacy of available revascularization treatments, a subgroup of patients continue suffering from ref
Transmyocardial laser revascularization versus medical therapy for refractory angina.
Briones E, Lacalle JR, Marin I. Briones E, et al. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD003712. doi: 10.1002/14651858.CD003712.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160223 Updated. Review.
Although the improved efficacy of available revascularization treatments, a subgroup of patients present with refractory angina. Transmyocardial laser revascularization (TMLR) has been proposed to improve the clinical situation of these patients. OBJECTIVES: To asse …
Although the improved efficacy of available revascularization treatments, a subgroup of patients present with refractory angina
The Impact of Cell Therapy on Cardiovascular Outcomes in Patients With Refractory Angina.
Jones DA, Weeraman D, Colicchia M, Hussain MA, Veerapen D, Andiapen M, Rathod KS, Baumbach A, Mathur A. Jones DA, et al. Circ Res. 2019 Jun 7;124(12):1786-1795. doi: 10.1161/CIRCRESAHA.118.314118. Epub 2019 Mar 29. Circ Res. 2019. PMID: 30922167
RATIONALE: Cell-based therapies are a novel potential treatment for refractory angina and have been found to improve markers of angina. ...OBJECTIVE: To investigate the efficacy and safety of stem cell treatment compared with optimal medical
RATIONALE: Cell-based therapies are a novel potential treatment for refractory angina and have been found to improve ma …
Percutaneous coronary intervention with optimal medical therapy vs. optimal medical therapy alone for patients with stable angina pectoris.
Gorenoi V, Schönermark MP, Hagen A. Gorenoi V, et al. GMS Health Technol Assess. 2011;7:Doc07. doi: 10.3205/hta000098. Epub 2011 Nov 10. GMS Health Technol Assess. 2011. PMID: 22205918 Free PMC article.
Otherwise, PCI is to be performed in patients with refractory or progressing AP despite of optimal medical therapy use; in this case PCI is expected to be applied in 27% to 30% of patients in five years. From the health economic view the routine use of …
Otherwise, PCI is to be performed in patients with refractory or progressing AP despite of optimal medical therapy
OSA and depression are common and independently associated with refractory angina in patients with coronary artery disease.
Geovanini GR, Gowdak LHW, Pereira AC, Danzi-Soares NJ, Dourado LOC, Poppi NT, Cesar LAM, Drager LF, Lorenzi-Filho G. Geovanini GR, et al. Chest. 2014 Jul;146(1):73-80. doi: 10.1378/chest.13-2885. Chest. 2014. PMID: 24811214

OBJECTIVE: Refractory angina is a severe form of coronary artery disease (CAD) characterized by persistent angina despite optimal medical therapy. ...OSA (P = .017), depression (P < .001), higher Epworth Sleepiness Scale score (P = .00

OBJECTIVE: Refractory angina is a severe form of coronary artery disease (CAD) characterized by persistent angina despi …
Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials.
Velagapudi P, Turagam M, Kolte D, Khera S, Hyder O, Gordon P, Aronow HD, Leopold J, Abbott JD. Velagapudi P, et al. Cardiovasc Revasc Med. 2019 Mar;20(3):215-219. doi: 10.1016/j.carrev.2018.05.018. Epub 2018 Jun 5. Cardiovasc Revasc Med. 2019. PMID: 29908826
BACKGROUND: Previous studies have demonstrated that intramyocardial human CD34+ cells may relieve symptoms and improve clinical outcomes in chronic refractory angina unresponsive to optimal medical therapy or not amenable to revascularization. M …
BACKGROUND: Previous studies have demonstrated that intramyocardial human CD34+ cells may relieve symptoms and improve clinical outcomes in …
Effectiveness of percutaneous laser revascularization therapy for refractory angina.
McGillion M, Cook A, Victor JC, Carroll S, Weston J, Teoh K, Arthur HM. McGillion M, et al. Vasc Health Risk Manag. 2010 Sep 7;6:735-47. doi: 10.2147/vhrm.s8222. Vasc Health Risk Manag. 2010. PMID: 20859544 Free PMC article. Review.
Refractory angina is a debilitating disease characterized by persistent cardiac pain resistant to all conventional treatments for coronary artery disease. ...We used meta-analysis to assess the effectiveness of PMLR versus optimal medical therapy
Refractory angina is a debilitating disease characterized by persistent cardiac pain resistant to all conventional treatments
Spinal Cord Stimulation 50 Years Later: Clinical Outcomes of Spinal Cord Stimulation Based on Randomized Clinical Trials-A Systematic Review.
Mekhail N, Visnjevac O, Azer G, Mehanny DS, Agrawal P, Foorsov V. Mekhail N, et al. Reg Anesth Pain Med. 2018 May;43(4):391-406. doi: 10.1097/AAP.0000000000000744. Reg Anesth Pain Med. 2018. PMID: 29481371
Twenty-one randomized controlled trials were analyzed (7 for trunk and limb pain, inclusive of failed back surgery syndrome; 8 for refractory angina pectoris; 1 for cardiac X syndrome; 3 for critical limb ischemia; 2 for complex regional pain syndrome; and 2 …
Twenty-one randomized controlled trials were analyzed (7 for trunk and limb pain, inclusive of failed back surgery syndrome; 8 for refrac
Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
Stone GW, Hochman JS, Williams DO, Boden WE, Ferguson TB Jr, Harrington RA, Maron DJ. Stone GW, et al. J Am Coll Cardiol. 2016 Jan 5;67(1):81-99. doi: 10.1016/j.jacc.2015.09.056. Epub 2015 Nov 23. J Am Coll Cardiol. 2016. PMID: 26616030 Free PMC article. Review.
All patients with stable ischemic heart disease (SIHD) should be managed with guideline-directed medical therapy (GDMT), which reduces progression of atherosclerosis and prevents coronary thrombosis. ...The ongoing ISCHEMIA trial (International Study of Comparative …
All patients with stable ischemic heart disease (SIHD) should be managed with guideline-directed medical therapy (GDMT), which …
Current medical management of chronic stable angina.
Thadani U. Thadani U. J Cardiovasc Pharmacol Ther. 2004 Sep;9 Suppl 1:S11-29; quiz S98-9. doi: 10.1177/107424840400900103. J Cardiovasc Pharmacol Ther. 2004. PMID: 15378129 Review.
From the available data, an initial trial of medical treatment with anti-anginal drugs and strategies to reduce adverse clinical outcomes (smoking cessation, daily aspirin, treatment of dyslipidemias and hypertension) is indicated in most patients with stable angina
From the available data, an initial trial of medical treatment with anti-anginal drugs and strategies to reduce adverse clinical outc …
33 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page